Cite
HARVARD Citation
Jin, X. et al. (2020). Use of Tregs as a cell‐based therapy via CD39 for benign prostate hyperplasia with inflammation. Journal of cellular and molecular medicine. 24 (9), pp. 5082-5096. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Jin, X. et al. (2020). Use of Tregs as a cell‐based therapy via CD39 for benign prostate hyperplasia with inflammation. Journal of cellular and molecular medicine. 24 (9), pp. 5082-5096. [Online].